CRW Insider Trading

Insider Ownership Percentage: 21.39%
Insider Buying (Last 12 Months): £89,884.05
Insider Selling (Last 12 Months): GBX 0

Craneware Insider Trading History Chart

This chart shows the insider buying and selling history at Craneware by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Craneware Share Price & Price History

Current Price: GBX 1,240
Price Change: +0.30 (1.20%)
As of 03/27/2023 05:42 PM ET

This chart shows the closing price history over time for CRW up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Craneware Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/13/2023Keith NeilsonInsiderBuy3,484GBX 1,435£49,995.40
2/1/2023Keith NeilsonInsiderBuy1,384GBX 1,445£19,998.80
1/26/2023Keith NeilsonInsiderBuy1,367GBX 1,455£19,889.85
9/22/2021Keith NeilsonInsiderBuy2,128GBX 2,350£50,008
See Full Table

SEC Filings (Institutional Ownership Changes) for Craneware (LON:CRW)

53.37% of Craneware stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Craneware logo
Craneware plc, together with its subsidiaries, develops, licenses, and supports computer software for the healthcare industry in the United States. The company provides solutions, such as Trisus pricing transparency software; Trisus Pricing Analyzer, a solution that simplifies and automates the price modeling process; Trisus Chargemaster, an automated chargemaster management solution; InSight Medical Necessity, a solution that offers medical necessity for the United States payors; Trisus Claims Informatics, a retrospective charge capture analytical application that identifies areas of risk for its team to investigate; Trisus Supply, a solution that improves supplies reimbursement; and InSight Audit, an audit management solution for government and commercial payors. It also offers InSight Denials to analyze, track, trend, and report on denial data; Trisus Healthcare Intelligence, a solution that provides insights into resource consumption on the patient level; Trisus Medication Analytic solutions; and Trisus supplies assistant solutions. In addition, the company provides Sentinel, a drug tracking solution; Sentrex, a SaaS-based solution that helps covered entities expand medication access; Sentrex 330; Referral Verification System; and Sentry Core, a solution that simplifies the complexities of pharmacy procurement, utilization, and compliances. Further, it offers appeal and professional services. Craneware plc was incorporated in 1999 and is headquartered in Edinburgh, the United Kingdom.
Read More on Craneware

Today's Range

Now: GBX 1,240
Low: 1,230
High: 1,240

50 Day Range

MA: GBX 1,481.49
Low: 1,240
High: 1,920

52 Week Range

Now: GBX 1,240
Low: 1,210
High: 2,250


19,825 shs

Average Volume

124,785 shs

Market Capitalization

£440.70 million

P/E Ratio


Dividend Yield




Who are the company insiders with the largest holdings of Craneware?

Craneware's top insider investors include:
  1. Keith Neilson (Insider)
Learn More about top insider investors at Craneware.